|
| Exchange Received Time 03/12/2019 17:43:00 Exchange Disseminated Time 03/12/2019 17:43:14 Time Taken 00:00:14 | LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/12/2019 ,inter alia, to consider and approve This is to inform you that applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, December 07, 2019 at the Registered Office of the Company inter-alia to consider the following:
1. To Withdrawal the In-principle application and Draft Scheme filed with NSE, earlier approved by the Board of Directors in its meeting held on September 19, 2019, on the ground that there is an error in considering relevant date according to SEBI Circular CFD/DIL3/CIR/2017/21 dated March 10, 2017.
2. To consider and approve draft scheme of amalgamation of Lincoln Parenteral Limited ('Transferor Company') with Lincoln Pharmaceuticals Limited ('Transferee Company'), subject to necessary approvals.
3. Any other businesses with the permission of the Board.
|
|
|